IBB
IBB
iShares Biotechnology ETF • IShares
$176.66 ▲ 1.46% (+2.54)
Managing Company IShares
Asset Under Management $8.54B
Inception Date Feb 5, 2001
Expense Ratio 0.44%
52w High $179.64
52w Low $116.25
Volume 1,255,866
Avg Volume 1,749,727
Asset Class Equity
About iShares Biotechnology ETF
The iShares Biotechnology ETF seeks to track the investment results of an index composed of U.S.-listed equities in the biotechnology sector.
Managing Company IShares
Asset Under Management $8.54B
Inception Date Feb 5, 2001
Expense Ratio 0.44%
52w High $179.64
52w Low $116.25
Volume 1,255,866
Avg Volume 1,749,727
Asset Class Equity
About iShares Biotechnology ETF
The iShares Biotechnology ETF seeks to track the investment results of an index composed of U.S.-listed equities in the biotechnology sector.
HOLDINGS (Top 20)
| Stock | Name | Weight | Shares | Market Value |
|---|---|---|---|---|
 GILD | Gilead Sciences, Inc. | 7.47% | 4.51M | $625.00M |
 AMGN | Amgen Inc. | 7.23% | 1.73M | $604.91M |
 VRTX | Vertex Pharmaceuticals Incorporated | 7.06% | 1.38M | $609.89M |
 REGN | Regeneron Pharmaceuticals, Inc. | 6.75% | 773.20K | $582.94M |
 ALNY | Alnylam Pharmaceuticals, Inc. | 3.74% | 978.62K | $313.29M |
 ARGX | argenx SE | 3.38% | 341.21K | $282.64M |
 INSM | Insmed Incorporated | 2.71% | 1.59M | $226.50M |
 NTRA | Natera, Inc. | 2.40% | 999.98K | $207.19M |
 RVMD | Revolution Medicines, Inc. | 2.31% | 1.31M | $199.59M |
 BIIB | Biogen Inc. | 2.29% | 1.09M | $191.85M |
 UTHR | United Therapeutics Corporation | 2.15% | 321.74K | $185.83M |
 ONC | BeOne Medicines Ltd. | 2.00% | 539.59K | $172.64M |
 ILMN | Illumina, Inc. | 1.75% | 1.11M | $146.81M |
 MRNA | Moderna, Inc. | 1.72% | 2.74M | $148.89M |
 INCY | Incyte Corporation | 1.67% | 1.47M | $139.78M |
 ROIV | Roivant Sciences Ltd. | 1.26% | 3.71M | $109.07M |
 GMAB | Genmab A/S | 1.20% | 3.55M | $100.50M |
 BBIO | BridgeBio Pharma, Inc. | 1.15% | 1.24M | $95.91M |
 NBIX | Neurocrine Biosciences, Inc. | 1.13% | 741.87K | $97.51M |
 IONS | Ionis Pharmaceuticals, Inc. | 1.08% | 1.20M | $90.64M |
SECTOR HOLDINGS
HealthcareASSET ALLOCATION BY REGION
United States
Netherlands
Denmark
United Kingdom
Canada
Germany
Ireland
France
Switzerland
China
Singapore
Jersey
Belgium
Spain
Australia
Cayman Islands Other
0.06%
Italy
Iceland.svg)
Taiwan (Province of China)SECTOR HOLDINGS
HealthcareASSET ALLOCATION BY REGION
United States Netherlands Denmark United Kingdom Canada Germany Ireland France Switzerland China Singapore Jersey Belgium Spain Australia Cayman Islands Other
0.06% Italy Iceland Taiwan (Province of China)Holdings (Top 20)
GILD
Gilead Sciences, Inc.
Weight: 7.47% Shares: 4.51M Value: $625.00M
AMGN
Amgen Inc.
Weight: 7.23% Shares: 1.73M Value: $604.91M
VRTX
Vertex Pharmaceuticals Incorporated
Weight: 7.06% Shares: 1.38M Value: $609.89M
REGN
Regeneron Pharmaceuticals, Inc.
Weight: 6.75% Shares: 773.20K Value: $582.94M
ALNY
Alnylam Pharmaceuticals, Inc.
Weight: 3.74% Shares: 978.62K Value: $313.29M
ARGX
argenx SE
Weight: 3.38% Shares: 341.21K Value: $282.64M
INSM
Insmed Incorporated
Weight: 2.71% Shares: 1.59M Value: $226.50M
NTRA
Natera, Inc.
Weight: 2.40% Shares: 999.98K Value: $207.19M
RVMD
Revolution Medicines, Inc.
Weight: 2.31% Shares: 1.31M Value: $199.59M
BIIB
Biogen Inc.
Weight: 2.29% Shares: 1.09M Value: $191.85M
UTHR
United Therapeutics Corporation
Weight: 2.15% Shares: 321.74K Value: $185.83M
ONC
BeOne Medicines Ltd.
Weight: 2.00% Shares: 539.59K Value: $172.64M
ILMN
Illumina, Inc.
Weight: 1.75% Shares: 1.11M Value: $146.81M
MRNA
Moderna, Inc.
Weight: 1.72% Shares: 2.74M Value: $148.89M
INCY
Incyte Corporation
Weight: 1.67% Shares: 1.47M Value: $139.78M
ROIV
Roivant Sciences Ltd.
Weight: 1.26% Shares: 3.71M Value: $109.07M
GMAB
Genmab A/S
Weight: 1.20% Shares: 3.55M Value: $100.50M
BBIO
BridgeBio Pharma, Inc.
Weight: 1.15% Shares: 1.24M Value: $95.91M
NBIX
Neurocrine Biosciences, Inc.
Weight: 1.13% Shares: 741.87K Value: $97.51M
IONS
Ionis Pharmaceuticals, Inc.
Weight: 1.08% Shares: 1.20M Value: $90.64M